AIG
SNNA

American International Group’s Sienna Biopharmaceuticals, Inc. SNNA Stock Holding History

American International Group’s Portfolio SNNA Stock Details SNNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-10,026
Closed -$23K – 3208
2019
Q1 		$23K Sell
10,026
-124
-1% -$336 ﹤0.01% 2987
2018
Q4 		$24K Sell
10,150
-79
-0.8% -$696 ﹤0.01% 3007
2018
Q3 		$152K Buy
10,229
+184
+2% +$2.92K ﹤0.01% 2602
2018
Q2 		$153K Buy
10,045
+391
+4% +$6.64K ﹤0.01% 2529
2018
Q1 		$181K Buy
9,654
+6,262
+185% +$109K ﹤0.01% 2326
2017
Q4 		$62K Buy
3,392
+127
+4% +$2.69K ﹤0.01% 2904
2017
Q3 		$73K Buy
+3,265
New +$71.7K ﹤0.01% 2747

Other funds holding SNNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $950M AUM 57.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
WCM
Wildcat Capital Management New York $106M AUM 0.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return